藤井輝久

フジイテルヒサ | Fujii Teruhisa

所属機関・部署：
論文 (9件)：

Fujii, Teruhisa, Kidoguchi, Yuko, Takahashi, Noriko, Yu, Eric, Ainiwaer, Dilinuer, Byrne, Aidan. Budget impact analysis of Jivi (damoctocog alfa pegol, Bay 94-9027) in severe hemophilia A in Japan. JOURNAL OF MEDICAL ECONOMICS. 2021. 24. 1. 218-225
Kagiura, Fumiko, Fujii, Teruhisa, Kihana, Nobuko, Maruyama, Eiko, Shimoji, Yuka, Kakehashi, Masayuki. Brief HIV stigma scale for Japanese people living with HIV: validation and restructuring using questionnaire survey data. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. 2020. 32. 1-9
Weather changes leading to bleeding in arthropathic joints among individuals with haemophilia: symptoms of meteoropathy?. 2020. 26. 6. 346-248
Shintani, T., Fujii, T., Yamasaki, N., Kitagawa, M., Iwata, T., Saito, S., Okada, M., Ogawa, I., Unei, H., Hamamoto, K., et al. Oral environment and taste function of Japanese HIV-infected patients treated with antiretroviral therapy. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. 2020. 32. 7. 829-834
Long-term impact of haemarthrosis on arthropathy and activities of daily living in Japanese persons with haemophilia. 2020. 26. 3. 124-127

講演・口頭発表等 (3件)：

ウイルス学的寛解を継続していてもCD4数が増加しない原因に関する探索的研究
(第34回日本エイズ学会学術集会 2020)
BUDGET IMPACT ANALYSIS OF BAY-94 9027 (DAMOCTOCOG ALFA PEGOL) IN SEVERE HEMOPHILIA A (HA) IN JAPAN
(第82回日本血液学会学術集会 2020)
Plasma factor VIII activity measured by coagulation one-stage and chromogenic assays in patients with hemophilia A treated with emicizumab
(XXVIII Congress of the International Society on Thromobosis and Haemostasis 2020)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

藤井 輝久